DK316788D0 - Farmaceutisk praeparat og dets anvendelse - Google Patents

Farmaceutisk praeparat og dets anvendelse

Info

Publication number
DK316788D0
DK316788D0 DK316788A DK316788A DK316788D0 DK 316788 D0 DK316788 D0 DK 316788D0 DK 316788 A DK316788 A DK 316788A DK 316788 A DK316788 A DK 316788A DK 316788 D0 DK316788 D0 DK 316788D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
enantiomers
mixtures
compositions
contain
Prior art date
Application number
DK316788A
Other languages
English (en)
Other versions
DK171746B1 (da
DK316788A (da
Inventor
John Michael Pawelchak
James Ronald Lawter
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK316788D0 publication Critical patent/DK316788D0/da
Publication of DK316788A publication Critical patent/DK316788A/da
Application granted granted Critical
Publication of DK171746B1 publication Critical patent/DK171746B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
DK316788A 1987-06-12 1988-06-10 Transdermalt afgivelsessystem DK171746B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6184287A 1987-06-12 1987-06-12
US6184287 1987-06-12

Publications (3)

Publication Number Publication Date
DK316788D0 true DK316788D0 (da) 1988-06-10
DK316788A DK316788A (da) 1988-12-13
DK171746B1 DK171746B1 (da) 1997-05-05

Family

ID=22038497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK316788A DK171746B1 (da) 1987-06-12 1988-06-10 Transdermalt afgivelsessystem

Country Status (16)

Country Link
EP (1) EP0294601B1 (da)
JP (1) JP2654092B2 (da)
KR (1) KR970000506B1 (da)
AT (1) ATE84714T1 (da)
AU (1) AU609142B2 (da)
CA (1) CA1305418C (da)
DE (1) DE3877630T2 (da)
DK (1) DK171746B1 (da)
ES (1) ES2043719T3 (da)
GR (1) GR3006938T3 (da)
IE (1) IE62735B1 (da)
IL (1) IL86334A (da)
NO (1) NO178096C (da)
NZ (1) NZ224891A (da)
PT (1) PT87704B (da)
ZA (1) ZA884186B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin
US5476854A (en) * 1991-11-27 1995-12-19 Sepracor Inc. Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
ES2199954T3 (es) * 1992-11-09 2004-03-01 Neurogesx, Inc. Administracion transdermica de cetorolac.
ATE526973T1 (de) 2001-06-18 2011-10-15 Noven Pharma Verbesserte arzneimittelabgabe in transdermalen systemen
CA2525970C (en) 2003-05-15 2011-03-22 Roskamp Research, Llc Use of nilvadipine for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
JP5411145B2 (ja) 2007-10-05 2014-02-12 アルツハイマーズ・インスティテュート・オブ・アメリカ・インコーポレイテッド （−）−ニルバジピンエナンチオマーによってアミロイド沈着、アミロイド神経毒性、およびミクログリオーシスを減少させる方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPS6016917A (ja) * 1983-07-08 1985-01-28 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンまたはニフエジピンの軟膏剤
JPS60258179A (ja) * 1984-06-04 1985-12-20 Yamanouchi Pharmaceut Co Ltd Ｙｍ−０９７３０のジアステレオマ−ａの右旋性光学異性体またはその酸付加塩，該化合物の製造方法および該化合物からなる医薬
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE3877630D1 (de) 1993-03-04
IE881749L (en) 1988-12-12
EP0294601A3 (en) 1989-10-11
ES2043719T3 (es) 1994-01-01
IL86334A (en) 1992-09-06
JP2654092B2 (ja) 1997-09-17
GR3006938T3 (da) 1993-06-30
CA1305418C (en) 1992-07-21
ZA884186B (en) 1989-03-29
JPS6413024A (en) 1989-01-17
PT87704B (pt) 1993-03-31
AU1761088A (en) 1988-12-15
KR970000506B1 (ko) 1997-01-13
KR890000090A (ko) 1989-03-11
DK171746B1 (da) 1997-05-05
NO882559D0 (no) 1988-06-10
NO178096C (no) 1996-01-24
EP0294601A2 (en) 1988-12-14
PT87704A (pt) 1988-07-01
DK316788A (da) 1988-12-13
IE62735B1 (en) 1995-02-22
ATE84714T1 (de) 1993-02-15
NO882559L (no) 1988-12-13
NZ224891A (en) 1992-06-25
DE3877630T2 (de) 1993-06-03
NO178096B (no) 1995-10-16
EP0294601B1 (en) 1993-01-20
AU609142B2 (en) 1991-04-26

Similar Documents

Publication Publication Date Title
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
SE8404065D0 (sv) Novel biologically active compounds
IT9048524A0 (it) Composizione adesiva stabilizzante per protesi dentarie.
DK316788A (da) Farmaceutisk praeparat og dets anvendelse
DK376188A (da) Farmaceutisk dosisenhed
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
DK598288D0 (da) Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen
DE3877063D1 (de) Photopolymerisierbare dentalzusammensetzung.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
DK561589D0 (da) Flydende oralt farmaceutisk praeparat
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
ES2019634B3 (es) Terapia con clorfeniramina.
DE3866419D1 (de) Photopolymerisierbare dentalzusammensetzung.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
CS318690A3 (en) Pharmaceutical composition usable for depression therapy
IT9048526A0 (it) Composizione adesiva stabilizzante anidra per protesi dentarie.
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
DK226688A (da) Middel til behandling og forebyggelse af asthma

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired